Covid-19: from structure to therapeutic targeting in studying approved drugs and local DNA vaccination.

Covid-19: from structure to therapeutic targeting in studying approved drugs and local DNA vaccination. Clin Exp Pharmacol Physiol. 2020 Sep 25;: Authors: Wang Z, Hong X, Wang H, Liu J, Liu JP Abstract The coronavirus disease 2019 (COVID-19) pandemic presents an unprecedented threat to global public health. The spread of the severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) infections in a global scale has affected more than 30.6 million people suffering the COVID-19, resulting in more than 955,000 deaths globally as of the 20 September 2020. The current lack of specific and effective therapies for the COVID-19, and the continuous spread of coronavirus SARS-CoV-2 across many parts of the world, represent one of the major challenges in controlling the disease severity, keeping to pose a huge threat to the global health. PMID: 32976637 [PubMed - as supplied by publisher]
Source: Clinical and Experimental Pharmacology and Physiology - Category: Drugs & Pharmacology Authors: Tags: Clin Exp Pharmacol Physiol Source Type: research